Prevalence of SARS-CoV-2 Antibodies among Federally Incarcerated Women

In collaboration with Public Health Agency of Canada (PHAC) and the University of Ottawa, Correctional Service Canada (CSC) conducted the 2022 National Health Survey. One of the study objectives was to determine the prevalence of SARS-CoV-2 antibodies and whether they are derived from immunization or infection among federally incarcerated women.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 19:08 (TU)
Créé le avril 17, 2026, 19:08 (TU)
contact_email OpenGovernmentGEN-NHQ@CSC-SCC.GC.CA
criticality_level ["general_public", "government", "scientists", "women"]
geographic_scope []
open_canada_collection publication
open_canada_date_published 2024-03-11 00:00:00
open_canada_keywords {"fr": ["L'Enquête nationale sur la santé de 2022", "épidémiologie", "incarcération", "délinquantes femmes", "SARS-CoV-2", "COVID-19", "vaccination", "ASPC", "SCC"], "en": ["2022 National health survey", "epidemiology", "incarceration", "women offenders", "SARS-CoV-2", "COVID-19", "vaccination", "PHAC", "University of Ottawa", "CSC"]}
open_canada_subject ["law"]
sensitivity_level unrestricted
title_fr Prévalence d’anticorps contre le SRAS-CoV-2 chez les femmes incarcérées dans les établissements fédéraux
update_frequency as_needed